Duloxetine + Pregabalin + Placebo
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Neuropathy, Painful
Conditions
Diabetic Neuropathy, Painful
Trial Timeline
Mar 1, 2010 → Nov 1, 2011
NCT ID
NCT01089556About Duloxetine + Pregabalin + Placebo
Duloxetine + Pregabalin + Placebo is a phase 3 stage product being developed by Eli Lilly for Diabetic Neuropathy, Painful. The current trial status is completed. This product is registered under clinical trial identifier NCT01089556. Target conditions include Diabetic Neuropathy, Painful.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01089556 | Phase 3 | Completed |
Competing Products
20 competing products in Diabetic Neuropathy, Painful